-
Published 6/30/2025
Chiang CH, Chang YC, Yu CC, See XY, Wang TH, Xanthavanij N, Song J, Lo SW, Chiang CH, Lake L, Lauw MN, Bauer KA, Kazi DS, Patell R. Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2025 Nov; 23(11):3527-3539. PMID: 40602613.
-
Published 5/27/2025
Chiang CH, Song J, Chang YC, Osataphan S, Lee YC, Chang KY, Chi KY, Chiang CH, Dua A, Lake L, Lauw MN, Bauer KA, Kazi DS, Patell R. Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation. Blood Adv. 2025 May 27; 9(10):2410-2418. PMID: 39908569.
-
Published 4/22/2025
Chaudhry SA, Haj AK, Ryu J, Jurgens SJ, Rodriguez Espada A, Wang X, Choi SH, Sanna-Cherchi S, Grover SP, Bauer KA, Ellinor PT, Bendapudi PK. Population-Scale Studies of Protein S Abnormalities and Thrombosis. JAMA. 2025 Apr 22; 333(16):1423-1432. PMID: 40029645.
-
Published 10/21/2024
Barnum KJ, Patell R, Berry J, Bauer KA. Splanchnic vein thrombosis: management for the thrombosis specialist. J Thromb Haemost. 2025 Feb; 23(2):404-416. PMID: 39442623.
-
Published 6/6/2024
Ryu J, Rämö JT, Jurgens SJ, Niiranen T, Sanna-Cherchi S, Bauer KA, Haj A, Choi SH, Palotie A, Daly M, Ellinor PT, Bendapudi PK. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank. Blood. 2024 Jun 06; 143(23):2425-2432. PMID: 38498041.